Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.58%89.29M | -17.26%81.43M | -1.70%86.25M | 2.87%372.84M | -3.77%91.11M | 5.76%95.58M | 15.63%98.41M | -4.93%87.74M | -16.54%362.45M | -3.91%94.68M |
| Cost of revenue | -9.66%82.8M | -18.69%75.73M | 0.24%80.29M | 5.96%352.78M | 0.09%87.89M | 9.01%91.66M | 21.32%93.14M | -4.94%80.1M | -16.79%332.93M | -12.08%87.82M |
| Gross profit | 65.36%6.49M | 8.02%5.7M | -22.09%5.95M | -32.07%20.05M | -53.16%3.21M | -37.60%3.92M | -36.76%5.28M | -4.84%7.64M | -13.71%29.52M | 608.04%6.86M |
| Operating expense | 10.11%5.13M | 31.43%5.29M | -4.79%5.03M | 6.84%19.34M | 9.15%5.18M | 4.00%4.66M | -6.01%4.02M | 10.51%5.28M | 23.79%18.11M | 635.80%4.74M |
| Selling and administrative expenses | ---- | ---- | ---- | 4.76%20.83M | ---- | ---- | ---- | ---- | 9.89%19.88M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 16.41%4.04M | ---- | ---- | ---- | ---- | 57.63%3.47M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 2.29%16.78M | ---- | ---- | ---- | ---- | 3.27%16.41M | ---- |
| Other operating expenses | 7.44%5.56M | 19.15%5.92M | -2.34%5.71M | -5.71%529.94K | -0.02%5.67M | 9.25%5.17M | -1.17%4.97M | 12.81%5.85M | -10.13%562.06K | 138.41%5.67M |
| Total other operating income | -16.76%427K | -33.12%632K | 20.42%684K | -13.95%2.01M | -46.82%494K | 101.97%513K | 26.51%945K | 39.90%568K | -42.89%2.34M | -65.40%929K |
| Operating profit | 284.38%1.36M | -67.12%412K | -60.73%928K | -93.78%709.63K | -192.50%-1.96M | -140.73%-736K | -69.15%1.25M | -27.38%2.36M | -41.71%11.41M | 206.28%2.12M |
| Net non-operating interest income (expenses) | 48.51%-224K | 16.67%-370K | -34.38%-555K | 4.89%-1.86M | -67.86%-564K | 32.56%-435K | 31.48%-444K | -27.86%-413K | 19.29%-1.95M | 50.01%-336K |
| Non-operating interest income | 53.66%126K | 13.01%139K | -19.11%127K | -36.55%426.18K | -36.63%64K | -56.61%82K | -4.65%123K | -37.70%157K | 16.96%671.68K | -51.74%101K |
| Non-operating interest expense | -32.30%350K | -10.23%509K | 19.65%682K | -13.00%2.28M | 43.71%628K | -38.01%517K | -27.03%567K | -0.87%570K | -12.33%2.62M | -50.42%437K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 222.09%210K | -220.50%-172K | ||||||||
| Less:Write off | ---- | ---- | ---- | -222.09%-210K | ---- | ---- | ---- | ---- | 220.50%172K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 196.75%1.13M | -94.81%42K | -80.87%373K | -110.08%-936.64K | -241.54%-2.53M | -200.77%-1.17M | -76.30%809K | -33.47%1.95M | -46.32%9.29M | 170.67%1.78M |
| Income tax | 128.10%34K | -117.49%-46K | -63.06%133K | -94.88%159.9K | -147.17%-342K | -117.93%-121K | -72.14%263K | -53.91%360K | -25.29%3.13M | 790.32%725K |
| Net income | 204.67%1.1M | -83.88%88K | -84.91%240K | -117.78%-1.1M | -306.14%-2.18M | -315.61%-1.05M | -77.89%546K | -26.05%1.59M | -53.02%6.17M | 143.77%1.06M |
| Net income continuous operations | 204.67%1.1M | -83.88%88K | -84.91%240K | -117.78%-1.1M | -306.14%-2.18M | -315.61%-1.05M | -77.89%546K | -26.05%1.59M | -53.02%6.17M | 143.77%1.06M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 204.67%1.1M | -83.88%88K | -84.91%240K | -117.78%-1.1M | -306.14%-2.18M | -315.61%-1.05M | -77.89%546K | -26.05%1.59M | -53.02%6.17M | 143.77%1.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 204.67%1.1M | -83.88%88K | -84.91%240K | -117.78%-1.1M | -306.14%-2.18M | -315.61%-1.05M | -77.89%546K | -26.05%1.59M | -53.02%6.17M | 143.77%1.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 203.33%0.31 | -81.25%0.0003 | -84.78%0.0007 | -117.51%-0.0031 | -310.00%-0.0063 | -314.29%-0.3 | -77.46%0.0016 | -25.81%0.0046 | -52.93%0.0177 | 143.48%0.003 |
| Diluted earnings per share | 203.33%0.31 | -81.25%0.0003 | -84.78%0.0007 | -117.51%-0.0031 | -310.00%-0.0063 | -314.29%-0.3 | -77.46%0.0016 | -25.81%0.0046 | -52.93%0.0177 | 143.48%0.003 |
| Dividend per share | 0 | 0 | 0 | -25.00%0.015 | 0 | 0 | -25.00%0.015 | 0 | -33.33%0.02 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.